HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group
- PMID: 9377119
- DOI: 10.1097/00042560-199709010-00002
HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group
Abstract
The relations among serum HIV RNA levels, CD4 cell counts, presence of the mutant CCR5-allele in heterozygous form, and clinical outcome was analyzed in 96 patients from the Copenhagen AIDS Cohort. In the early years of the infection, patients with the CCR5 delta32/CCR5 genotype had significantly lower HIV RNA levels (p = 0.005) and higher CD4 cell counts (p < 0.005) than did patients homozygous for the normal allele. The long-term clinical benefit of being heterozygous is small and cannot solely explain the large interpatient variation in progression rates. The beneficial effect of being heterozygous seems to be mediated by events in the early stages of the HIV infection.
Similar articles
-
MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.AIDS. 1998 May 7;12(7):729-36. doi: 10.1097/00002030-199807000-00009. AIDS. 1998. PMID: 9619804
-
HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):229-33. doi: 10.1097/00042560-199807010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9665499
-
Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.HIV Med. 2007 May;8(4):213-9. doi: 10.1111/j.1468-1293.2007.00455.x. HIV Med. 2007. PMID: 17461848
-
Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.J Infect Dis. 2014 Dec 1;210(11):1838-43. doi: 10.1093/infdis/jiu338. Epub 2014 Jun 16. J Infect Dis. 2014. PMID: 24935955 Free PMC article.
-
HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.AIDS Rev. 2017 Dec;19(4):219-230. AIDS Rev. 2017. PMID: 28534889 Review.
Cited by
-
Factors Influencing Immune Restoration in People Living with HIV/AIDS.J Clin Med. 2022 Mar 28;11(7):1887. doi: 10.3390/jcm11071887. J Clin Med. 2022. PMID: 35407496 Free PMC article.
-
CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.J Infect Dis. 2003 Feb 15;187(4):569-75. doi: 10.1086/367995. Epub 2003 Jan 29. J Infect Dis. 2003. PMID: 12599073 Free PMC article.
-
Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.PLoS Med. 2006 Nov;3(11):e454. doi: 10.1371/journal.pmed.0030454. PLoS Med. 2006. PMID: 17090213 Free PMC article. Review.
-
The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10214-9. doi: 10.1073/pnas.181325198. Epub 2001 Aug 21. Proc Natl Acad Sci U S A. 2001. PMID: 11517319 Free PMC article.
-
HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues.Viruses. 2012 Oct 10;4(10):2080-96. doi: 10.3390/v4102080. Viruses. 2012. PMID: 23202454 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials